A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled study to evaluate the efficacy and safety of rezpegaldesleukin in adults with severe to very-severe alopecia areata

Authors

Stephen Schleicher MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

8-2024

Volume

191

Issue

2

Published In/Presented At

https://doi.org/10.1093/bjd/ljae266.097

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Article